Bendell JC, Rodon J, Burris HA. et al. Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors.
J Clin Oncol 2012; 30: 282-290
Download Bibliographical Data
We do not assume any responsibility for the contents of the web pages of other providers.